Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | MMP8 | P22894 | 1/20 | 0.46 |
| ▸ | MMP12 | P39900 | 1/20 | 0.46 |
| ▸ | MMP13 | P45452 | 1/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.42 |
| ▸ | LMNA | P02545 | 3/20 | 0.42 |
| ▸ | ACE | P12821 | 4/20 | 0.41 |
| ▸ | REN | P00797 | 2/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | F2 | P00734 | 1/20 | 0.41 |
| ▸ | LTA4H | P09960 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | PEPD | P12955 | 1/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.41 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.41 |
| ▸ | HTR2A | P28223 | 1/20 | 0.41 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3153775 | 1.00 | POLB (0.50) | POLBALDH1A1HTTMMP8MMP12 | |
| SCHEMBL697598 | 1.00 | POLB (0.50) | POLBALDH1A1HTTMMP8MMP12 | |
| SCHEMBL17327498 | 0.94 | ALDH1A1 (0.53) | POLBALDH1A1HTTMMP8MMP12 | |
| SCHEMBL17327496 | 0.94 | ALDH1A1 (0.53) | POLBALDH1A1HTTMMP8MMP12 | |
| SCHEMBL14594697 | 0.94 | ALDH1A1 (0.53) | POLBALDH1A1HTTMMP8MMP12 | |
| SCHEMBL17327489 | 0.89 | ALDH1A1 (0.41) | POLBALDH1A1HTTMMP8MMP12 | |
| SCHEMBL15746879 | 0.83 | TSHR (0.37) | POLBALDH1A1HTTKDM4E | |
| SCHEMBL16886885 | 0.82 | PLAU (0.36) | POLBALDH1A1KDM4E | |
| SCHEMBL16886888 | 0.82 | PLAU (0.36) | POLBALDH1A1KDM4E | |
| SCHEMBL3068881 | 0.82 | PER2 (0.38) | POLBALDH1A1MMP8MMP12MMP13 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1451 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122055449-A | Class 2V-type CRISPR-Cas lead editing | 巴斯夫农业解决方案美国有限责任公司 | 2026-05-15 | — | — | CN | claimed |
| CN-120060241-B | Base editor ACGBEmax for simultaneously realizing substitution of purine and pyrimidine | 中国农业大学 | 2026-05-15 | — | — | CN | claimed |
| CN-122012476-A | Difunctional deaminase with adenine and cytosine bidirectional deamination activity, mutant thereof, screening method and application | 深圳湾实验室 | 2026-05-12 | — | — | CN | claimed |
| CN-122012441-A | Herbicide resistance mutant of AhALS gene and application of herbicide resistance mutant in peanut breeding | 河南省农业科学院 | 2026-05-12 | — | — | CN | claimed |
| EP-4615416-A1 | SELF-ASSEMBLING LIPID NANOPARTICLES FOR TARGETED DELIVERY OF THERAPEUTIC AGENTS | Ramot at Tel-Aviv University Ltd. (IL) | 2025-09-17 | — | — | EP | claimed |
| CN-120041417-A | Sites linked with GBSS I protease activity and amylose synthesis and application thereof | 扬州大学 | 2025-05-27 | — | — | CN | claimed |
| CN-120005859-A | Compositions and methods for treating heme lesions | 比姆医疗股份有限公司 | 2025-05-16 | — | — | CN | claimed |
| CN-115992122-B | Cytosine base editor based on modified APOBEC3A of people | 江南大学 | 2025-05-16 | — | — | CN | claimed |
| CN-115992124-B | Cytosine base editor based on cynomolgus monkey APOBEC3A and mutant thereof | 江南大学 | 2025-05-13 | — | — | CN | claimed |
| CN-119955812-A | Breeding method and application for improving corn biomass and kernel yield through site-directed base mutation of corn ZmGRF1 gene | 中国农业科学院作物科学研究所 | 2025-05-09 | — | — | CN | claimed |
| CN-110880054-B | Planning method for electric network car-booking charging and battery-swapping path | 国网四川省电力公司天府新区供电公司 | 2022-05-20 | — | — | CN | claimed |
| WO-2022100662-A1 | GENOMIC EDITING OF IMPROVED EFFICIENCY AND ACCURACY | SHANGHAITECH UNIVERSITY (CN) | 2022-05-19 | — | — | WO | claimed |
| EP-3994257-A2 | HOST SYSTEMS COMPRISING INHIBITORS OF A GENE-EDITING PROTEIN FOR PRODUCTION OF VIRAL VECTORS | Asklepios Biopharmaceutical, Inc. (US) | 2022-05-11 | — | — | EP | claimed |
| CN-114437113-A | Thiazolopyridine ring-linked triazole compound and preparation method and application thereof | 西安交通大学 | 2022-05-06 | — | — | CN | claimed |
| CN-112539722-B | Method for measuring key machining error of double-crank cycloid wheel of speed reducer for robot | 华北水利水电大学 | 2022-05-06 | — | — | CN | claimed |
| US-20220127622-A1 | Compositions and Methods for Improving Base Editing | BEAM THERAPEUTICS INC. (US) | 2022-04-28 | — | — | US | claimed |
| CN-114072509-A | Nucleobase editor with reduced off-target of deamination and method of modifying nucleobase target sequence using same | 比姆医疗股份有限公司 | 2022-02-18 | — | — | CN | claimed |
| EP-1987035-A1 | HETEROCYCLIC ANTIVIRAL COMPOUNDS | F.HOFFMANN-LA ROCHE AG (CH) | 2008-11-05 | — | — | EP | claimed |
| WO-2007093515-A1 | HETEROCYCLIC ANTIVIRAL COMPOUNDS | F. HOFFMANN LA-ROCHE AG (CH) | 2007-08-23 | — | — | WO | claimed |
| US-20070191406-A1 | Heterocyclic antiviral compounds | ROCHE PALO ALTO LLC | 2007-08-16 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070191406-A1 | Heterocyclic antiviral compounds | CCR5, CX3CR1, CXCR1 | POLB 2278/4885ALDH1A1 2289/4885HTT 2886/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.